US Stock MarketDetailed Quotes

LIXT Lixte Biotechnology

Watchlist
  • 1.2700
  • +0.0199+1.59%
Close Mar 28 16:00 ET
  • 1.2800
  • +0.0100+0.79%
Post 18:20 ET
3.41MMarket Cap-0.80P/E (TTM)

Lixte Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.81%3.57M
-40.20%613.5K
-4.00%983.26K
-39.57%1.01M
-29.43%966.88K
-19.35%5.09M
-37.16%1.03M
-30.73%1.02M
8.02%1.67M
-17.18%1.37M
Selling and administrative expenses
-32.10%2.85M
-34.01%578.67K
-30.29%621.63K
-35.74%798.45K
-28.22%847.82K
-15.52%4.19M
-25.63%876.84K
-26.07%891.69K
-10.04%1.24M
-1.24%1.18M
-General and administrative expense
-32.10%2.85M
-34.01%578.67K
-30.29%621.63K
-35.74%798.45K
-28.22%847.82K
-15.52%4.19M
-25.63%876.84K
-26.07%891.69K
-10.04%1.24M
-1.24%1.18M
Research and development costs
-19.14%726.23K
-76.64%34.83K
172.96%361.63K
-50.71%210.71K
-37.03%119.06K
-33.44%898.1K
-67.14%149.07K
-51.36%132.49K
159.36%427.46K
-58.76%189.09K
Operating profit
29.81%-3.57M
40.20%-613.5K
4.00%-983.26K
39.57%-1.01M
29.43%-966.88K
19.35%-5.09M
37.16%-1.03M
30.73%-1.02M
-8.02%-1.67M
17.18%-1.37M
Net non-operating interest income expense
-879.97%-9.77K
36.86%-3.91K
-92.98%388
-350.78%-1.92K
-474.96%-4.33K
-45.99%1.25K
-285.04%-6.2K
208.59%5.53K
275.69%766
148.39%1.15K
Non-operating interest income
-59.69%7.05K
-86.85%519
-75.26%1.44K
-17.72%2.23K
-42.99%2.86K
56.19%17.49K
-43.47%3.95K
48.53%5.81K
1,320.94%2.71K
4,500.92%5.02K
Non-operating interest expense
3.62%16.82K
-56.31%4.43K
275.99%1.05K
113.24%4.15K
86.12%7.19K
82.91%16.23K
179.09%10.15K
-86.83%279
210.69%1.95K
54.81%3.86K
Other net income (expense)
-274.16%-3.4K
-91.89%-284
-2,800.00%-3.16K
-81.98%158
-108.70%-116
157.91%1.95K
92.73%-148
91.62%-109
517.61%877
837.02%1.33K
Gain on sale of security
-274.16%-3.4K
-91.89%-284
-2,800.00%-3.16K
-81.98%158
-108.70%-116
157.91%1.95K
92.73%-148
91.62%-109
517.61%877
837.02%1.33K
Income before tax
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
Income tax
Net income
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
Net income continuous Operations
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
Minority interest income
Net income attributable to the parent company
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
Basic earnings per share
40.23%-1.59
34.15%-0.27
10.20%-0.44
55.00%-0.45
47.56%-0.43
33.33%-2.66
58.16%-0.41
44.94%-0.49
-5.26%-1
31.67%-0.82
Diluted earnings per share
40.23%-1.59
34.15%-0.27
10.20%-0.44
55.00%-0.45
47.56%-0.43
33.33%-2.66
58.16%-0.41
44.94%-0.49
-5.26%-1
31.67%-0.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.81%3.57M-40.20%613.5K-4.00%983.26K-39.57%1.01M-29.43%966.88K-19.35%5.09M-37.16%1.03M-30.73%1.02M8.02%1.67M-17.18%1.37M
Selling and administrative expenses -32.10%2.85M-34.01%578.67K-30.29%621.63K-35.74%798.45K-28.22%847.82K-15.52%4.19M-25.63%876.84K-26.07%891.69K-10.04%1.24M-1.24%1.18M
-General and administrative expense -32.10%2.85M-34.01%578.67K-30.29%621.63K-35.74%798.45K-28.22%847.82K-15.52%4.19M-25.63%876.84K-26.07%891.69K-10.04%1.24M-1.24%1.18M
Research and development costs -19.14%726.23K-76.64%34.83K172.96%361.63K-50.71%210.71K-37.03%119.06K-33.44%898.1K-67.14%149.07K-51.36%132.49K159.36%427.46K-58.76%189.09K
Operating profit 29.81%-3.57M40.20%-613.5K4.00%-983.26K39.57%-1.01M29.43%-966.88K19.35%-5.09M37.16%-1.03M30.73%-1.02M-8.02%-1.67M17.18%-1.37M
Net non-operating interest income expense -879.97%-9.77K36.86%-3.91K-92.98%388-350.78%-1.92K-474.96%-4.33K-45.99%1.25K-285.04%-6.2K208.59%5.53K275.69%766148.39%1.15K
Non-operating interest income -59.69%7.05K-86.85%519-75.26%1.44K-17.72%2.23K-42.99%2.86K56.19%17.49K-43.47%3.95K48.53%5.81K1,320.94%2.71K4,500.92%5.02K
Non-operating interest expense 3.62%16.82K-56.31%4.43K275.99%1.05K113.24%4.15K86.12%7.19K82.91%16.23K179.09%10.15K-86.83%279210.69%1.95K54.81%3.86K
Other net income (expense) -274.16%-3.4K-91.89%-284-2,800.00%-3.16K-81.98%158-108.70%-116157.91%1.95K92.73%-14891.62%-109517.61%877837.02%1.33K
Gain on sale of security -274.16%-3.4K-91.89%-284-2,800.00%-3.16K-81.98%158-108.70%-116157.91%1.95K92.73%-14891.62%-109517.61%877837.02%1.33K
Income before tax 29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M
Income tax
Net income 29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M
Net income continuous Operations 29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M
Minority interest income
Net income attributable to the parent company 29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M
Basic earnings per share 40.23%-1.5934.15%-0.2710.20%-0.4455.00%-0.4547.56%-0.4333.33%-2.6658.16%-0.4144.94%-0.49-5.26%-131.67%-0.82
Diluted earnings per share 40.23%-1.5934.15%-0.2710.20%-0.4455.00%-0.4547.56%-0.4333.33%-2.6658.16%-0.4144.94%-0.49-5.26%-131.67%-0.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Cisco
CSCO
-0.88%
NVIDIA
NVDA
-1.58%
Broadcom
AVGO
-1.67%
Taiwan Semiconductor
TSM
-1.78%
ASML Holding
ASML
-2.32%

Unlock the Full List